Skip to main content
Gut logoLink to Gut
. 1963 Dec;4(4):378–393. doi: 10.1136/gut.4.4.378

Active `juvenile' cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy

A E Read, Sheila Sherlock, C V Harrison
PMCID: PMC1413482  PMID: 14084750

Abstract

This is a clinical study of 81 patients (32 male and 49 female), who are not alcoholics, with jaundice of hepato-cellular type lasting longer than three months. Forty-nine of these patients were under 21 years of age. The natural history of the condition and the response to corticosteroid therapy is described; good symptomatic relief can be achieved with corticosteroids but they do not seem to prolong life. The aetiology is discussed with special reference to the relationship to viral hepatitis, to systemic lupus erythematosus, and to other disturbances of immunity.

Full text

PDF
378

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARONSON A. R., MONTGOMERY M. M. Chronic liver disease with a "lupus erythematosus-like syndrome". Arch Intern Med. 1959 Oct;104:544–552. doi: 10.1001/archinte.1959.00270100030006. [DOI] [PubMed] [Google Scholar]
  2. BARTHOLOMEW L. G., CAIN J. C., BAGGENSTOSS A. H., HAGEDORN A. B. Further obervations on hepatitis and cirrhosis in young women with positive clot tests for lupus erythematousus. Gastroenterology. 1960 Dec;39:730–736. [PubMed] [Google Scholar]
  3. BARTHOLOMEW L. G., HAGEDORN A. B., CAIN J. C., BAGGENSTOSS A. H. Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus. N Engl J Med. 1958 Nov 13;259(20):947–956. doi: 10.1056/NEJM195811132592001. [DOI] [PubMed] [Google Scholar]
  4. BEARN A. G., KUNKEL H. G., SLATER R. J. The problem of chronic liver disease in young women. Am J Med. 1956 Jul;21(1):3–15. doi: 10.1016/0002-9343(56)90003-1. [DOI] [PubMed] [Google Scholar]
  5. BROBERGER O., PERLMANN P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959 Nov 1;110:657–674. doi: 10.1084/jem.110.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COHEN S., OHTA G., SINGER E. J., POPPER H. Immunocytochemical study of gamma globulin in liver in hepatitis and postnecrotic cirrhosis. J Exp Med. 1960 Feb 1;111:285–294. doi: 10.1084/jem.111.2.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Calabresi P., Thayer W. R., Spiro H. M. DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS. J Clin Invest. 1961 Dec;40(12):2126–2133. doi: 10.1172/JCI104438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FOURMAN P., McCANCE R. A. Tetany complicating the treatment of potassium deficiency in renal acidosis. Lancet. 1955 Feb 12;268(6859):329–331. doi: 10.1016/s0140-6736(55)90063-5. [DOI] [PubMed] [Google Scholar]
  9. FRICK E. Zur Serologie der multiplen Sklerose. Klin Wochenschr. 1954 May 15;32(19-20):450–452. doi: 10.1007/BF01466969. [DOI] [PubMed] [Google Scholar]
  10. GOOD R. A., PAGE A. R. Fatal complications of virus hepatitis in two patients with agammaglobulinemia. Am J Med. 1960 Nov;29:804–810. doi: 10.1016/0002-9343(60)90114-5. [DOI] [PubMed] [Google Scholar]
  11. GRAY N., MACKAY I. R., TAFT L. I., WEIDEN S., WOOD I. J. Hepatitis, colitis, and lupus manifestations. Am J Dig Dis. 1958 Jul;3(7):481–491. doi: 10.1007/BF02231247. [DOI] [PubMed] [Google Scholar]
  12. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  13. HELLER P., ZIMMERMAN H. J., ROZENGVAIG S., SINGER K. The L.E.-cell phenomenon in chronic hepatic disease. N Engl J Med. 1956 Jun 21;254(25):1160–1165. doi: 10.1056/NEJM195606212542503. [DOI] [PubMed] [Google Scholar]
  14. JESSAR R. A., LAMONT-HAVERS R. W., RAGAN C. Natural history of lupus erythematosus disseminatus. Ann Intern Med. 1953 Apr;38(4):717–731. doi: 10.7326/0003-4819-38-4-717. [DOI] [PubMed] [Google Scholar]
  15. JONES W. A., CASTLEMAN B. Liver disease in young women with hyperglobulinemia. Am J Pathol. 1962 Mar;40:315–329. [PMC free article] [PubMed] [Google Scholar]
  16. KENNY J. J., MOLONEY W. C. Multiple myeloma: diagnosis and management in a series of 57 cases. Ann Intern Med. 1957 Jun;46(6):1079–1091. doi: 10.7326/0003-4819-46-6-1079. [DOI] [PubMed] [Google Scholar]
  17. KLATSKIN G. Subacute hepatic necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus. Am J Med. 1958 Sep;25(3):333–358. doi: 10.1016/0002-9343(58)90072-x. [DOI] [PubMed] [Google Scholar]
  18. LAST P. M. The treatment of active chronic infectious hepatitis with ACTH (corticotrophin) and cortisone. Med J Aust. 1957 May 18;44(20):672–676. doi: 10.5694/j.1326-5377.1957.tb59755.x. [DOI] [PubMed] [Google Scholar]
  19. LUXTON R. W., COOKE R. T. Hashimoto's struma lymphomatosa; diagnostic value and significance of serum-flocculation reactions. Lancet. 1956 Jul 21;271(6934):105–109. doi: 10.1016/s0140-6736(56)90860-1. [DOI] [PubMed] [Google Scholar]
  20. MACKAY I. R., TAFT L. I., COWLING D. C. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet. 1959 Jan 10;1(7063):65–69. doi: 10.1016/s0140-6736(59)91136-5. [DOI] [PubMed] [Google Scholar]
  21. MACKAY I. R. The problem of persisting destructive disease of the liver. Gastroenterology. 1961 May;40:617–626. [PubMed] [Google Scholar]
  22. NAISH J. M. Autoclastic (lupoid) hepatitis. Br J Clin Pract. 1960 Oct;14:749–754. [PubMed] [Google Scholar]
  23. O'BRIEN E. N., GOBLE A. J., MACKAY I. R. Plasma-transaminase activity as an index of the effectiveness of cortisone in chronic hepatitis. Lancet. 1958 Jun 14;1(7033):1245–1249. doi: 10.1016/s0140-6736(58)92109-3. [DOI] [PubMed] [Google Scholar]
  24. OAKLEY W., FIELD J. B., SOWTON G. E., RIGBY B., CUNLIFFE A. C. Action of prednisone in insulin-resistant diabetes. Br Med J. 1959 Jun 27;1(5138):1601–1606. doi: 10.1136/bmj.1.5138.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. PAGE A. R., GOOD R. A. Plasma-cell hepatitis, with special attention to steroid therapy. AMA J Dis Child. 1960 Mar;99:288–314. doi: 10.1001/archpedi.1960.02070030290006. [DOI] [PubMed] [Google Scholar]
  26. PETERSON R. E. Adrenocortical steroid metabolism and adrenal cortical function in liver disease. J Clin Invest. 1960 Feb;39:320–331. doi: 10.1172/JCI104043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. RASKIN N. Antibrain antibodies in multiple sclerosis; study of the antibrain antibodies in the blood of multiple sclerosis patients by complement fixation tests. AMA Arch Neurol Psychiatry. 1955 Jun;73(6):645–655. [PubMed] [Google Scholar]
  28. ROITT I. M., DONIACH D. Human autoimmune thyroiditis: serological studies. Lancet. 1958 Nov 15;2(7055):1027–1033. doi: 10.1016/s0140-6736(58)90530-0. [DOI] [PubMed] [Google Scholar]
  29. SAINT E. G., KING W. E., JOSKE R. A., FINCKH E. S. The course of infectious hepatitis with special reference to prognosis and the chronic stage. Australas Ann Med. 1953 Nov;2(2):113–127. doi: 10.1111/imj.1953.2.2.113. [DOI] [PubMed] [Google Scholar]
  30. TAFT L. I., MACKAY I. R., COWLING D. C. Autoclasia: a perpetuacting mechanism in hepatitis. Gastroenterology. 1960 Apr;38:563–566. [PubMed] [Google Scholar]
  31. WILLIAMS R., BILLING B. H. Action of steroid therapy in jaundice. Lancet. 1961 Aug 19;2(7199):392–396. doi: 10.1016/s0140-6736(61)92481-3. [DOI] [PubMed] [Google Scholar]
  32. WILLOCX R. G., ISSELBACHER K. J. Chronic liver disease in young people. Clinical features and course in thirty-three patients. Am J Med. 1961 Feb;30:185–195. doi: 10.1016/0002-9343(61)90090-0. [DOI] [PubMed] [Google Scholar]
  33. ZIMMERMAN H. J., HELLER P., HILL R. P. Extreme hyperglobulinemia in subacute hepatic necrosis. N Engl J Med. 1951 Feb 15;244(7):245–249. doi: 10.1056/NEJM195102152440702. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES